Publications

Case Reports Letter Journal Article Ppublish

PubMed: 39900383 DOI: 10.1111/cge.14721

Digenic Inheritance of Monoallelic MUTYH and POLE Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy.

Clin Genet 107(6):699-701

Authors: Jonathan Lopez, Adrien Buisson, Adel Ounnas, Gaelle Tachon, Alain Viari, Florence De Fraipont, Juliette Albuisson, Marc Barritault, Pierre-Paul Bringuier, Jean-Paul Feugeas, Anne Mc Leer, Ahmed Bouras

Affiliations

  • GCS AURAGEN, Lyon, France. Biochemistry and Molecular Biology Department, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France.
  • GCS AURAGEN, Lyon, France.
  • Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Medical Unit of Molecular Genetics, Grenoble University Hospital, Grenoble, France.
  • Department of Pathology and Tumor Biology, Georges-François Leclerc Center, Dijon, France.
  • Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Laboratoire de Biochimie Hôpital Jean Minjoz, Université de Franche-Comté, Besançon, France.
  • Laboratory of Constitutional Genetics for Frequent Cancer HCL-CLB, Centre Léon Bérard, Lyon, France.

Abstract

Collision of monoallelic MUTYH and POLE germline variants in a patient with adrenocortical carcinoma who achieved a strong response to immunotherapy.

MeSH

Immunotherapy, Carcinogenesis, Adrenocortical Carcinoma, Genetics, Medical